mevalonic acid and Immunologic Deficiency Syndromes

mevalonic acid has been researched along with Immunologic Deficiency Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonneville, M; Catros, V; Léger, A; Robard, M; Santolaria, T; Scotet, E1

Other Studies

1 other study(ies) available for mevalonic acid and Immunologic Deficiency Syndromes

ArticleYear
Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
    Journal of immunology (Baltimore, Md. : 1950), 2013, Aug-15, Volume: 191, Issue:4

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Diphosphonates; Drug Administration Schedule; Humans; Immunologic Deficiency Syndromes; Immunotherapy, Adoptive; Lymphocyte Activation; Male; Mevalonic Acid; Mice; Mice, Mutant Strains; Mice, SCID; Pamidronate; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Xenograft Model Antitumor Assays

2013